SHC

In the past six months, Sotera Health Co. (SHC) reported strong first-quarter and second-quarter 2026 results, both exceeding market revenue and adjusted EPS expectations, leading to a slight raise in full-year 2026 guidance. The company announced secondary offerings of common stock in March and May 2026, and a leadership transition was also announced in May 2026. A significant legal development saw a Cook County jury decide that Sotera Health's Sterigenics unit was not liable for a woman's cancer, which caused a surge in the company's stock price. As of October 9, 2026, SHC shares were valued at $17.96, having fluctuated between $13.09 and $19.85 over the past year, showing a 13.02% increase.